I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| B cell | 25 studies | 23% ± 5% | |
| memory B cell | 16 studies | 21% ± 4% | |
| naive B cell | 12 studies | 21% ± 3% | |
| CD16-negative, CD56-bright natural killer cell, human | 9 studies | 19% ± 6% | |
| CD8-positive, alpha-beta T cell | 6 studies | 21% ± 6% | |
| smooth muscle cell | 6 studies | 22% ± 4% | |
| natural killer cell | 4 studies | 20% ± 4% | |
| endothelial cell | 4 studies | 21% ± 4% | |
| mast cell | 4 studies | 17% ± 2% | |
| gamma-delta T cell | 4 studies | 20% ± 2% | |
| T cell | 3 studies | 18% ± 2% | |
| CD4-positive, alpha-beta T cell | 3 studies | 16% ± 0% | |
| exhausted T cell | 3 studies | 25% ± 5% | |
| lymphocyte | 3 studies | 32% ± 5% | |
| GABAergic neuron | 3 studies | 20% ± 1% | |
| glutamatergic neuron | 3 studies | 25% ± 7% | |
| macrophage | 3 studies | 17% ± 1% | |
| regulatory T cell | 3 studies | 16% ± 0% | |
| brush cell | 3 studies | 23% ± 6% | |
| abnormal cell | 3 studies | 17% ± 1% |
